Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis.

Acute myeloid leukemia (AML) with mutated () is considered to have an unfavorable prognosis. However, recent studies have reported comparable survival outcomes with wild-type (). To assess the clinical outcomes of AML with and without , we performed a prospective cohort study and systematic review and meta-analysis.